Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and its prevalence is increasing with the ageing of the population. Presently available treatment options are far from optimal and new insights into underlying mechanisms are needed to improve therapy. A variety of recent lines of research are converging to reveal important and relatively underappreciated multidimensional roles of cellular Ca 2+ content, distribution, and handling in AF pathophysiology. The objective of the present paper is to review the participation of changes in cell Ca 2+ and related processes in the mechanisms that lead to AF initiation and maintenance, and to consider the relevance of new knowledge in this area to therapeutic innovation. We first review the involvement of Ca 2+ -related functions in the principal arrhythmia mechanisms underlying AF: focal ectopic activity due to afterdepolarizations and re-entrant mechanisms. The detailed molecular pathophysiology of focal ectopic and re-entrant activity is then discussed in relationship to the participation of cell Ca 2+ changes and related Ca 2+ -handling and Ca 2+ -sensitive signalling systems. We then go on to consider the participation of Ca 2+ -related functions in electrical and structural remodelling processes leading to the AF substrate. Finally, we consider the implications for development of new arrhythmia management approaches and future research and development.
Introduction
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and its evolving management is the subject of active consideration in Europe and North America. 1 Consideration of presently available therapeutic options indicates many important unanswered questions about underlying mechanisms, resolution of which is needed to improve AF management. 2 Several recent lines of research have converged to reveal an important and underappreciated role of Ca 2+ in AF pathophysiology. The objective of the present paper is to review the participation of changes in cell Ca 2+ and related processes in the mechanisms leading to AF initiation and maintenance, and to consider their relevance to the development of new treatment approaches.
Basic mechanistic determinants of atrial fibrillation and role of Ca 21 Figure 1 illustrates the basic electrophysiological mechanisms leading to AF, highlighting the role of Ca 2+ -related processes.
A brief overview will be presented here; for details see relevant review articles. 3, 4 Atrial fibrillation can be maintained by rapid focal ectopic activity (e.g. from the pulmonary veins) or by re-entry ( Figure 1A) . 3, 4 Re-entry requires a vulnerable substrate, as well as a trigger usually provided by spontaneous focal ectopic discharge. The most common causes of focal ectopic activity are afterdepolarizations ( Figure 1B 4 or late Na + current (I NaL ), 5 or by reduced K + currents], 4 allowing I CaL to recover from inactivation and depolarize the cell by allowing Ca 2+ to enter. Early afterdepolarizations cause ectopic firing by depolarizing surrounding tissue to excitation threshold. I NCX flows during the AP plateau and contributes to EAD-generating AP prolongation. Re-entry maintenance depends on critical refractoriness and conduction conditions ( Figure 1C) . The 'leading circle' concept (C ) Determinants of atrial fibrillation maintaining re-entrant activity. Left: wavelength ¼ refractory period × conduction velocity, determines size of functional re-entry circuits. Right: reduced wavelength allows more simultaneous circuits, making atrial fibrillation termination less likely. Wavelength can be reduced by decreased action potential duration. Ca 2+ -related functions that reduce wavelength include decreased posits that functional re-entry establishes itself in the minimum sized circuit for re-entry maintenance, given by the distance ('wavelength') the impulse travels in one refractory period (RP): wavelength ¼ RP × conduction velocity. 3 When the number of circuits that the atria can contain is small ( Figure 1C , left), re-entry is unstable and AF self-terminates. When the wavelength is reduced (e.g. when RP decreases), the circuits are smaller and more numerous, simultaneous termination of all circuits is unlikely, and AF is sustained ( Figure 1C , right). Refractory period depends on action potential duration (APD). Action potential duration is reduced by decreasing inward current (I CaL ), or by increasing outward K + current. Recent genomic work suggests that a Ca 2+ -dependent K + current plays an important role in AF, 4 likely by controlling APD.
Detailed role of Ca 21 -related processes in atrial fibrillationrelated afterdepolarizations
Delayed afterdepolarizations
A detailed analysis of Ca 2+ -related processes controlling DAD generation is depicted in Figure 2A . pacing-induced AF due to a gain-of-function RyR2 mutation is reversed by pharmacological or genetic inhibition of CaMKII or its specific RyR2 phosphorylation site, emphasizing the potential importance of CaMKII phosphorylation in AF. 9 The Ca 2+ sensitivity and closed state stability of RyR2 are also modulated by accessorybinding proteins such as FK506-binding protein (FKBP12.6), 4 and by accessory proteins such as junctophilin, triadin, calsequestrin, and junctin. 4, 6 Knock-out mice lacking FKBP12.6 exhibit focal atrial ectopy and vulnerability to pacing-induced AF caused by increased SR Ca 2+ leak, NCX activation, and DADs. can also contribute to AF by phosphorylating histone deacetylase (HDAC), derepressing hypertrophic, ion channel, and ion transporter gene expression. Ryanodine receptor 2 phosphorylation is also controlled by dephosphorylation via type 1 (PP1) and type 2A (PP2A) protein phosphatases ( Figure 3 ). Inhibitor 1 protein (which specifically suppresses PP1 activity in the SR) is activated by PKA hyperphosphorylation in AF patients. 12 Inhibitor 1 activation reduces 
Early afterdepolarizations
Early afterdepolarizations result from factors that increase APD ( Figure 1B) . Several molecular changes can contribute to atrial EADs by prolonging APD ( Figure 2B) . Late Na + current (I NaL ) is increased in AF patients, 16 possibly because of enhanced CaMKII activity, 9 increasing plateau inward current and prolonging APD.
Atrial fibrillation related to EAD mechanisms may also result from gain-of-function mutations in I CaL or I Na that cause Long-QT Syndrome. 17, 18 Calcineurin is a Ca 2+ /calmodulin-sensitive phosphatase, which dephosphorylates nuclear factor of activated T-cells (NFAT), allowing NFAT to translocate to the nucleus. 27 Nuclear factor of activated T-cells translocation regulates mRNA transcription, leading to decreased mRNA expression of the L-type Ca 2+ channel pore-forming a-subunit, decreased I CaL and reduced APD/Ca 2+ loading. 27 Cell Ca 2+ loading also contributes to K + current up-regulation.
In addition to its regulation of I CaL , NFAT also binds to regulatory DNA regions upstream to the sites encoding the pre-microRNA (miR) corresponding to miR26, inhibiting its transcription. 29 Consequently, miR26 expression is down-regulated in AF. 29 Structural remodelling is an important contributor to AF pathopysiology. 4, 35, 36 Structural remodelling occurs both at cellular ( Figure 5A ) and tissue ( Figure 5B ) levels. Atrial cardiomyocytes exposed to long-term rapid activation show loss of myofibrils, glycogen accumulation, mitochondrial changes, chromatin and connexin redistribution. 35, 37 These changes are reminiscent of hibernating myocardium; while they may be autoprotective, they might also contribute to AF promotion and atrial contractile impairment.
37
Ca 2+ -dependent calpain activation plays a central role in myofilament degeneration. 38 Angiotensin-II is an important contributor to AF-related remodelling; 3,4 angiotensin-II-induced changes in gene expression may be signalled via nuclear-localized angiotensin receptors coupled to gene expression via nuclear Ca 2+ mobilization through inositol trisphosphate receptor Ca 2+ channels. 39 Atrial fibroblasts are activated in AF, proliferate, and differentiate into collagen-secreting myofibroblasts. 40 Myofibroblast accumulation can contribute to AF both via direct electrical interactions with cardiomyocytes and by enhanced secretion of extracellular matrix (ECM) proteins such as collagen, 40 inducing atrial fibrosis that interferes with muscle bundle continuity and impairs conduction, thereby promoting re-entry. 41 Fibrosis contributes to the AF substrate in many patients, particularly under conditions of atrial dilation/stretch like heart failure. 42 Recent work suggests that Ca 2+ entry through non-selective transient receptor potential (TRP) channels TRPM7 and/or TRPC3 is central to AF-related fibroblast activation. 43, 44 Fibroblasts from AF patients show up-regulated TRPM7 currents and enhanced Ca 2+ entry, along with enhanced myofibroblast differentiation, all of which are suppressed by TRPM7 knockdown. 43 Fibroblast TRPC3 expression is increased in AF, mediates angiotensin-induced Ca 2+ entry, and contributes to fibroblast proliferation/differentiation. 44 Interestingly, TRPC3 expression appears to be controlled by miR26, 44 creating a link between signalling for electrical and structural remodelling. Rapidly firing atrial cardiomyocytes discharge substances that promote fibroblast differentiation, potentially contributing to the atrial fibrosis and therapeutic resistance that develop with longstanding AF. 4 Altered myofibroblast K + channel expression can favour AF promotion by influencing electrical interactions with cardiomyocytes and/or affecting Ca 2+ -regulated ECM protein production.
45 Figure 4 Tachycardia-induced electrical remodelling that promotes re-entry. Atrial fibrillation promotes its own maintenance via action potential duration abbreviation and cell membrane hyperpolarization. Ca 2+ loading is a key cellular signal. Direct Ca
2+
-related processes are shown in red, downstream changes in green, and atrial fibrillation promoting electrophysiological alterations in blue. 
Conclusions
A great deal has been learned about the role of Ca 2+ in AF. Ca 2+ -related processes are central to basic atrial arrhythmia mechanisms and to a variety of extremely important AF-promoting remodelling paradigms. Appreciating these processes has given us important new insights into the pathophysiology underlying AF, and will hopefully in due course provide a variety of safe and effective new treatment options. Conflict of interest: none declared.
